Skip to main content
Premium Trial:

Request an Annual Quote

Biodesix Closes on $20M Series D Round

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biodesix has closed on a $20 million Series D financing round, the company announced yesterday.

The funds will go toward commercialization of its VeriStrat test for non-small cell lung cancer, for which the company plans to pursue clearance from the US Food and Drug Administration. Ongoing collaborations with biotechnology and pharmaceutical firms interested in using diagnostic tests to identify appropriate patients for targeted cancer therapies will also be supported with the funds, Biodesix said.

"This new investment will allow Biodesix to broaden and accelerate commercialization activities for VeriStrat, including expanding our studies of VeriStrat’s utility in other solid tumors and with new drug combinations that can significantly improve outcomes for cancer patients," CEO David Brunel said in a statement.

The round was led by existing investors, which Biodesix called "a small group of industry insiders."

Biodesix disclosed the round in a document filed with the US Securities and Exchange Commission last week, and a company spokesman told GenomeWeb Daily News that it had closed on the first of two tranches of the round.

In November, Biodesix completed a Series C financing round that raised $7.1 million.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.